Amobarbital; Barbital; Butabarbital; Butalbital; Meprobamate; Methaqualone; Pentobarbital; Phenobarbital; Secobarbital
Back to Test Catalogue
Barbiturates and Sedatives Screen, Serum/Plasma
Test ID: DS11
Test
Method
GC-FID and HPLC
Method Description
Analysis includes initial GC-FID Screenand confirmatory quantitation by HPLC.
Report Includes
Specimens
Avoid gel separator tubes; Serum; Plasma (Heparin); Plasma(EDTA)
Test Location
Hospital for Sick Children, 555 University Avenue, Toronto ON M5G 1X8
Test Version
25-May-2022
Specimen
Specimens
Avoid gel separator tubes; Serum; Plasma (Heparin); Plasma(EDTA)
Sample Volume
1 mL
Specimen Comment
Avoid gel separator tubes.
Additional Information
Analysis includes initial GC-FID Screen and confirmatory quantitation by HPLC.
Stability
| Refrigerated | 7 days |
|---|---|
| Frozen | >7 days |
Rejection Criteria
| Specimen | Gel-separator tube |
|---|
Test Version
25-May-2022
Performance / Interpretation
Method
GC-FID and HPLC
Method Description
Analysis includes initial GC-FID Screenand confirmatory quantitation by HPLC.
Turnaround Time
3 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Barbital | µmol/L |
|
||
| Butabarbital | µmol/L |
|
||
| Butalbital | µmol/L |
|
||
| Amobarbital | µmol/L |
|
||
| Pentobarbital | µmol/L |
|
||
| Secobarbital | µmol/L |
|
||
| Phenobarbital | µmol/L |
|
||
| Meprobamate | µmol/L |
|
||
| Methaqualone | µmol/L |
|
||
Test Location
Hospital for Sick Children, 555 University Avenue, Toronto ON M5G 1X8
Test Version
25-May-2022
Interface / Setup
Test Version
25-May-2022